FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361004388> ?p ?o ?g. }

• W4361004388 abstract "The rapid emergence and spread of vaccine/antibody-escaping variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed serious challenges to our efforts in combating corona virus disease 2019 (COVID-19) pandemic. A potent and broad-spectrum neutralizing reagent against these escaping mutants is extremely important for the development of strategies for the prevention and treatment of SARS-CoV-2 infection. We herein report an abiotic synthetic antibody inhibitor as a potential anti-SARS-CoV-2 therapeutic agent. The inhibitor, Aphe-NP14, was selected from a synthetic hydrogel polymer nanoparticle library created by incorporating monomers with functionalities complementary to key residues of the SARS-CoV-2 spike glycoprotein receptor binding domain (RBD) involved in human angiotensin-converting enzyme 2 (ACE2) binding. It has high capacity, fast adsorption kinetics, strong affinity, and broad specificity in biologically relevant conditions to both the wild type and the current variants of concern, including Beta, Delta, and Omicron spike RBD. The Aphe-NP14 uptake of spike RBD results in strong blockage of spike RBD–ACE2 interaction and thus potent neutralization efficacy against these escaping spike protein variant pseudotyped viruses. It also inhibits live SARS-CoV-2 virus recognition, entry, replication, and infection in vitro and in vivo. The Aphe-NP14 intranasal administration is found to be safe due to its low in vitro and in vivo toxicity. These results establish a potential application of abiotic synthetic antibody inhibitors in the prevention and treatment of the infection of emerging or possibly future SARS-CoV-2 variants." @default.
• W4361004388 created "2023-03-30" @default.
• W4361004388 creator A5000432967 @default.
• W4361004388 creator A5005531650 @default.
• W4361004388 creator A5016696094 @default.
• W4361004388 creator A5017574120 @default.
• W4361004388 creator A5023882890 @default.
• W4361004388 creator A5027030295 @default.
• W4361004388 creator A5035125487 @default.
• W4361004388 creator A5039837606 @default.
• W4361004388 creator A5043733392 @default.
• W4361004388 creator A5066602086 @default.
• W4361004388 creator A5072110295 @default.
• W4361004388 creator A5089431390 @default.
• W4361004388 date "2023-03-27" @default.
• W4361004388 modified "2023-10-16" @default.
• W4361004388 title "Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants" @default.
• W4361004388 cites W1975304761 @default.
• W4361004388 cites W1986869254 @default.
• W4361004388 cites W2058257207 @default.
• W4361004388 cites W2072623061 @default.
• W4361004388 cites W2087744863 @default.
• W4361004388 cites W2116007286 @default.
• W4361004388 cites W2282166877 @default.
• W4361004388 cites W2417073168 @default.
• W4361004388 cites W2566984024 @default.
• W4361004388 cites W2598358736 @default.
• W4361004388 cites W2803653389 @default.
• W4361004388 cites W2906329418 @default.
• W4361004388 cites W2998885045 @default.
• W4361004388 cites W3007643904 @default.
• W4361004388 cites W3009335299 @default.
• W4361004388 cites W3009906937 @default.
• W4361004388 cites W3009912996 @default.
• W4361004388 cites W3010441732 @default.
• W4361004388 cites W3013800395 @default.
• W4361004388 cites W3014067025 @default.
• W4361004388 cites W3015190630 @default.
• W4361004388 cites W3015313862 @default.
• W4361004388 cites W3022435472 @default.
• W4361004388 cites W3029682964 @default.
• W4361004388 cites W3031869875 @default.
• W4361004388 cites W3032255042 @default.
• W4361004388 cites W3036505266 @default.
• W4361004388 cites W3045600629 @default.
• W4361004388 cites W3087282025 @default.
• W4361004388 cites W3105996820 @default.
• W4361004388 cites W3112356527 @default.
• W4361004388 cites W3117730334 @default.
• W4361004388 cites W3128260795 @default.
• W4361004388 cites W3137152384 @default.
• W4361004388 cites W3144827625 @default.
• W4361004388 cites W3153636933 @default.
• W4361004388 cites W3162361711 @default.
• W4361004388 cites W3165032628 @default.
• W4361004388 cites W3165479483 @default.
• W4361004388 cites W3171186796 @default.
• W4361004388 cites W3186455315 @default.
• W4361004388 cites W3194545253 @default.
• W4361004388 cites W3194731062 @default.
• W4361004388 cites W3203433659 @default.
• W4361004388 cites W3216416458 @default.
• W4361004388 cites W3216605334 @default.
• W4361004388 cites W4200180765 @default.
• W4361004388 cites W4206634366 @default.
• W4361004388 cites W4213003635 @default.
• W4361004388 cites W4214527258 @default.
• W4361004388 cites W4224256795 @default.
• W4361004388 cites W4225094299 @default.
• W4361004388 cites W4226087845 @default.
• W4361004388 cites W4297328591 @default.
• W4361004388 cites W435335180 @default.
• W4361004388 doi "https://doi.org/10.1021/acsnano.3c02050" @default.
• W4361004388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36971310" @default.
• W4361004388 hasPublicationYear "2023" @default.
• W4361004388 type Work @default.
• W4361004388 citedByCount "0" @default.
• W4361004388 crossrefType "journal-article" @default.
• W4361004388 hasAuthorship W4361004388A5000432967 @default.
• W4361004388 hasAuthorship W4361004388A5005531650 @default.
• W4361004388 hasAuthorship W4361004388A5016696094 @default.
• W4361004388 hasAuthorship W4361004388A5017574120 @default.
• W4361004388 hasAuthorship W4361004388A5023882890 @default.
• W4361004388 hasAuthorship W4361004388A5027030295 @default.
• W4361004388 hasAuthorship W4361004388A5035125487 @default.
• W4361004388 hasAuthorship W4361004388A5039837606 @default.
• W4361004388 hasAuthorship W4361004388A5043733392 @default.
• W4361004388 hasAuthorship W4361004388A5066602086 @default.
• W4361004388 hasAuthorship W4361004388A5072110295 @default.
• W4361004388 hasAuthorship W4361004388A5089431390 @default.
• W4361004388 hasBestOaLocation W43610043881 @default.
• W4361004388 hasConcept C140704245 @default.
• W4361004388 hasConcept C14086860 @default.
• W4361004388 hasConcept C159047783 @default.
• W4361004388 hasConcept C159654299 @default.
• W4361004388 hasConcept C185592680 @default.
• W4361004388 hasConcept C203014093 @default.
• W4361004388 hasConcept C207001950 @default.
• W4361004388 hasConcept C2522874641 @default.
• W4361004388 hasConcept C2779261636 @default.

• next